Hagey Laboratory for Pediatric Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA.
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.
Ann Surg. 2021 Jan 1;273(1):173-180. doi: 10.1097/SLA.0000000000003255.
The aim of this study was to determine the interaction of full thickness excisional wounds and tumors in vivo.
Tumors have been described as wounds that do not heal due to similarities in stromal composition. On the basis of observations of slowed tumor growth after ulceration, we hypothesized that full thickness excisional wounds would inhibit tumor progression in vivo.
To determine the interaction of tumors and wounds, we developed a tumor xenograft/allograft (human head and neck squamous cell carcinoma SAS/mouse breast carcinoma 4T1) wound mouse model. We examined tumor growth with varying temporospatial placement of tumors and wounds or ischemic flap. In addition, we developed a tumor/wound parabiosis model to understand the ability of tumors and wounds to recruit circulating progenitor cells.
Tumor growth inhibition by full thickness excisional wounds was dose-dependent, maintained by sequential wounding, and relative to distance. This effect was recapitulated by placement of an ischemic flap directly adjacent to a xenograft tumor. Using a parabiosis model, we demonstrated that a healing wound was able to recruit significantly more circulating progenitor cells than a growing tumor. Tumor inhibition by wound was unaffected by presence of an immune response in an immunocompetent model using a mammary carcinoma. Utilizing functional proteomics, we identified 100 proteins differentially expressed in tumors and wounds.
Full thickness excisional wounds have the ability to inhibit tumor growth in vivo. Further research may provide an exact mechanism for this remarkable finding and new advances in wound healing and tumor biology.
本研究旨在确定体内全层切除创面与肿瘤的相互作用。
肿瘤被描述为由于基质组成相似而无法愈合的创面。基于溃疡后肿瘤生长减缓的观察结果,我们假设全层切除创面会抑制体内肿瘤的进展。
为了确定肿瘤和创面的相互作用,我们开发了一种肿瘤异种移植物/同种移植物(人头颈鳞状细胞癌 SAS/小鼠乳腺癌 4T1)创面小鼠模型。我们通过改变肿瘤和创面或缺血皮瓣的时空位置来检查肿瘤生长。此外,我们还开发了一种肿瘤/创面联体模型,以了解肿瘤和创面募集循环祖细胞的能力。
全层切除创面对肿瘤生长的抑制作用呈剂量依赖性,通过连续创伤维持,并与距离有关。这一效应通过将缺血皮瓣直接放置在异种移植物肿瘤旁边得到了再现。通过联体模型,我们证明了愈合创面比生长中的肿瘤能够募集更多的循环祖细胞。在免疫功能正常的乳腺癌模型中,免疫反应的存在对创面抑制肿瘤的作用没有影响。利用功能蛋白质组学,我们鉴定了 100 种在肿瘤和创面中差异表达的蛋白质。
全层切除创面具有抑制体内肿瘤生长的能力。进一步的研究可能会为这一显著发现提供确切的机制,并为创面愈合和肿瘤生物学提供新的进展。